Drugs / Ketamine Hcl 50Mg/Ml Inj
last change May 2023 re-read 3 minutes ago

Ketamine Hcl 50Mg/Ml Inj

Developed for
delirium

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
— NCT05341154 Comparator Dec 2021 → May 2023 delirium Huda Fahmy Mahmoud, PhD Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Ketamine Hcl 50Mg/Ml Inj ClinicalTrials.gov intervention name — accepted as the source's own label NCT05341154 ↗